Data / Form D filings / IGM Biosciences, Inc.
IGM Biosciences, Inc.: Form D filings
IGM Biosciences, Inc., a biotechnology company in Mountain View, CA, filed 2 Form D notices with the SEC between 2010 and 2023. The latest, on July 7, 2023, reports $22.5 million sold of a $22.5 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 325 E MIDDLEFIELD ROAD, Mountain View, CA, 94043
- Phone
- (650) 965-7873
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- $1,000,001 - $5,000,000
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1496323
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 7, 2023 | New notice | $22,500,000 | $22,500,000 | 1 | Jun 26, 2023 | sec.gov | |
| Jul 16, 2010 | New notice | $3,802,789 | $1,302,789 | $2,500,000 | 7 | Jul 2, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Felix J. Baker | Director | |
| George A Gauthier | Executive Officer | |
| Fred M. Schwarzer | Executive Officer, Director | |
| Misbah A Tahir | Executive Officer | |
| Lisa L. Decker | Executive Officer | |
| Michael J. Loberg | Director | |
| William J. Strohl | Director | |
| Bruce A Keyt | Executive Officer | |
| M. Kathleen J. Behrens | Director | |
| Julie J. Hambleton | Director | |
| Chris H. Takimoto | Executive Officer | |
| Jakob Haldor Topsoe | Director | |
| Christina Teng Topsoe | Director | |
| Michael J. Lee | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Jul 3, 2023 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what IGM Biosciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.